Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription 04.05.2026 17 Alzheimers Dement 1 BMJ 1 Brain 2 Exp Neurol 1 Geriatrics (Basel) 3 J Alzheimers Dis 1 J Am Geriatr Soc 1 J Neurol 1 Lancet 1 Nat Neurosci 1 Neurobiol Aging 1 PLoS One 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimers Dement

1. LUO QH, Li F, Yang L, Pan HQ, et al
   Endothelial NAD(+) depletion drives vascular senescence and neuroinflammation via mtDNA-cGAS/STING-CD38 signaling in Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71423.
   PubMed         Abstract available
   
   
2. BONTA KM, Li JS, Tun SM, Fredericks CA, et al
   Sleep duration and amyloid status moderate the association between mood symptoms and amygdalar tau in preclinical Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71447.
   PubMed         Abstract available
   
   
3. OLIVEIRA MC
   The forgotten population: Early-onset Alzheimer's in people with Down syndrome.
   Alzheimers Dement. 2026;22:e71311.
   PubMed         Abstract available
   
   
4. ZHANG X, Wang G, Chen H, Sun Y, et al
   Human iPSC-derived GABAergic interneuron transplantation restores circuit balance and cognitive function in an Alzheimer's disease model.
   Alzheimers Dement. 2026;22:e71378.
   PubMed         Abstract available
   
   
5. RAY NR, Kurup J, Kumar A, Rajabli F, et al
   Genetic correlation analysis of Alzheimer's disease and stroke implicates PHLPP1 as a shared locus in individuals of African ancestry.
   Alzheimers Dement. 2026;22:e71433.
   PubMed         Abstract available
   
   
6. FARRELL C, Saini F, Beidas MM, Ryan NS, et al
   Use of anti-amyloid-beta monoclonal antibodies in persons with Down syndrome Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71404.
   PubMed         Abstract available
   
   
7. CHONG CHIE JAK, Persohn SA, Pandey RS, Simcox OR, et al
   Multiscale metabolic covariance networks uncover stage-specific biomarker signatures across the Alzheimer's disease continuum.
   Alzheimers Dement. 2026;22:e71218.
   PubMed         Abstract available
   
   
8. PHARES S, Kremer I, Wall JK, Wood J, et al
   System changes to empower primary care in Alzheimer's disease detection and care.
   Alzheimers Dement. 2026;22:e71276.
   PubMed         Abstract available
   
   
9. DOS REIS S, Tran P, Mohanty K, Amill-Rosario A, et al
   Reduced risk of dementia with recombinant zoster vaccine in US adults age 65 or older.
   Alzheimers Dement. 2026;22:e71407.
   PubMed         Abstract available
   
   
10. TAO Q, Han J, Ang TFA, Hou L, et al
    Peripheral vascular function, including endothelium-dependent measures, and dementia risk: The Framingham Heart Study.
    Alzheimers Dement. 2026;22:e71396.
    PubMed         Abstract available
    
    
11. ARAVENA JM, Castro H, Poblete R, Saavedra G, et al
    Designing a communication strategy to promote Alzheimer's disease prevention: The CULTIVAMENTE campaign.
    Alzheimers Dement. 2026;22:e71448.
    PubMed         Abstract available
    
    
12. XU Y, Denkinger MN, Liu M, Gong K, et al
    GPND-AI NULISA: A 15-Protein AI classifier for diagnosis and co-pathology profiling across neurodegenerative diseases.
    Alzheimers Dement. 2026;22:e71420.
    PubMed         Abstract available
    
    
13. GIMENEZ S, Vaque-Alcazar L, Clos S, Benejam B, et al
    Characterizing circadian rest-activity rhythm patterns across Alzheimer's disease continuum in Down syndrome.
    Alzheimers Dement. 2026;22:e71409.
    PubMed         Abstract available
    
    
14. HENRIQUEZ F, Riquelme P, Forno G, Migeot J, et al
    Activities of daily living and their neural correlates across the Alzheimer's disease continuum: Evidence from a Latin American cohort.
    Alzheimers Dement. 2026;22:e71445.
    PubMed         Abstract available
    
    
15. VAZQUEZ-GUAJARDO M, Mimenza-Alvarado AJ, Martinez-Zamora CA, Lee A, et al
    Bibliometric analysis of Alzheimer's and dementia research in Latin America.
    Alzheimers Dement. 2026;22:e71395.
    PubMed         Abstract available
    
    
16. SONG Z, Huang X, Jannu AJ, Johnson TS, et al
    Identification of Alzheimer's disease subtypes and biomarkers from human multi-omics data using subspace merging algorithm.
    Alzheimers Dement. 2026;22:e71292.
    PubMed         Abstract available
    
    
17. O'SHEA DM, Wang L, Lukacsovich D, Dhanekula D, et al
    Development and validation of MethylCog, a blood DNA methylation proxy for cognition.
    Alzheimers Dement. 2026;22:e71421.
    PubMed         Abstract available
    
    

    
    BMJ

18. BRAYNE C, Richard E
    Innovation in Alzheimer's disease needs more than pharmaceutical solutions.
    BMJ. 2026;393:s788.
    PubMed        
    
    

    
    Brain

19. TOSUN D
    APOE shifts the tipping point: addressing pathological heterogeneity in Alzheimer's disease trials.
    Brain. 2026 Apr 29:awag151. doi: 10.1093.
    PubMed        
    
    

    
    Exp Neurol

20. KAUR A, Singh S, Singh M, Silakari P, et al
    Corrigendum to "Demethyleneberberine attenuates combined cognitive and metabolic dysfunctions in an insulin-resistance-induced Alzheimer's disease rat model: Synthesis, in-silico and in-vivo insights" [Experimental Neurology, 398 (2026) 115634].
    Exp Neurol. 2026 Apr 23:115774. doi: 10.1016/j.expneurol.2026.115774.
    PubMed        
    
    
21. GAO Q, Sun J, Hei B, Zhou J, et al
    Vitamin E and melatonin synergistically attenuate sleep deprivation-induced Nrf2 dysregulation and hippocampal ferroptosis in Alzheimer's disease mouse models.
    Exp Neurol. 2026;402:115781.
    PubMed         Abstract available
    
    

    
    Geriatrics (Basel)

22. ALLEGRA P, Lodico M, Migliazzo C, Tarantino D, et al
    The Need for Standardized Data Collection to Improve Harmonization and Pooling of Information About Modifiable Risk Factors for Alzheimer's Diseases in Italian Clinical Studies: A Systematic Review.
    Geriatrics (Basel). 2026;11:38.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

23. DHANA K, Aggarwal NT, Arfanakis K, Sacks FM, et al
    Dietary intervention and cognition across Alzheimer's disease biomarker levels: The MIND clinical trial.
    J Alzheimers Dis. 2026 Apr 25:13872877261442856. doi: 10.1177/13872877261442856.
    PubMed         Abstract available
    
    
24. ERUYSAL E, Ravdin L, Iadecola C, Ishii M, et al
    Associations of circulating resistin with Alzheimer's disease biomarkers and cognitive function in the preclinical stage of Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 28:13872877261442230. doi: 10.1177/13872877261442230.
    PubMed         Abstract available
    
    
25. LEE M, Kim M
    Donepezil increases angiogenic potential in patients with Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 29:13872877261444020. doi: 10.1177/13872877261444020.
    PubMed         Abstract available
    
    

    
    J Am Geriatr Soc

26. HODGSON NA, Latif S, Talwar S, Huang L, et al
    Multi-State Implementation of the Alzheimer's Association Dementia Care Coordination (DCC) Program.
    J Am Geriatr Soc. 2026 Apr 30. doi: 10.1111/jgs.70475.
    PubMed         Abstract available
    
    

    
    J Neurol

27. BRIEL N, Borsi M, Schreiner SJ, Schneider T, et al
    Outcome associations of CSF total tau in suspected non-Alzheimer pathophysiology.
    J Neurol. 2026;273:296.
    PubMed         Abstract available
    
    

    
    Lancet

28. FOX NC, Kohlhaas S, Schott JM
    Alzheimer's disease immunotherapy and the amyloid hypothesis: when aggregation obscures interpretation.
    Lancet. 2026 Apr 23:S0140-6736(26)00789-0. doi: 10.1016/S0140-6736(26)00789.
    PubMed        
    
    

    
    Nat Neurosci

29. CHOI DJ, Murali S, Kwon W, Woo J, et al
    Author Correction: Astrocytic Sox9 overexpression in Alzheimer's disease mouse models promotes Abeta plaque phagocytosis and preserves cognitive function.
    Nat Neurosci. 2026 Apr 24. doi: 10.1038/s41593-026-02312.
    PubMed        
    
    

    
    Neurobiol Aging

30. YANG B, Earnest T, Bilgel M, Albert MS, et al
    Predicting future cognitive impairment in preclinical Alzheimer's disease using amyloid PET and MRI: A multisite machine learning study.
    Neurobiol Aging. 2026;165:8-23.
    PubMed         Abstract available
    
    

    
    PLoS One

31. ROSALES-GURMENDI DS, Fumagal-Gonzalez GA, Orozco J, Farber J, et al
    Interpretable multivariate survival models: Improving predictions for conversion from mild cognitive impairment to Alzheimer's disease via data fusion and machine learning.
    PLoS One. 2026;21:e0321671.
    PubMed         Abstract available
    
    

    
    Science

32. DE STROOPER B, Zetterberg H
    Tracking the turning point in Alzheimer's disease.
    Science. 2026;392:468-469.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum